Abstract 4358112: Integrative Epigenomic and Single-Cell Transcriptomic Profiling of Thoracic Aortic Aneurysms

T Talal El Zarif (Yale University School of Medicine, New Haven, Connecticut, United States) D Dustin Lieu (Yale University School of Medicine, New Haven, Connecticut, United States) P Patryk Dabek (Yale University School of Medicine, New Haven, Connecticut, United States) S Sam Fenske (Yale University School of Medicine, New Haven, Connecticut, United States) A Ashley Fung (Yale University School of Medicine, New Haven, Connecticut, United States) J Joshua Yon (Yale University School of Medicine, New Haven, Connecticut, United States) A Alan Chou (Yale University School of Medicine, New Haven, Connecticut, United States) G Georgio Maroun (Yale University School of Medicine, New Haven, Connecticut, United States) P Pengwei Ren G George Tellides R Roland Assi (Yale University, New Haven, Connecticut, United States) H Hattie Chung (Yale University School of Medicine, New Haven, Connecticut, United States)

Abstract

Introduction: Thoracic aortic aneurysms (TAAs) affect up to 1% of the population. Transcriptional regulation governs vascular smooth muscle cell (VSMC) phenotypic plasticity, yet upstream epigenomic mechanisms remain poorly defined. Here, we characterize the epigenomic cis -regulatory landscape of sporadic TAAs to uncover regulatory features driving VSMC dysfunction. Methods: We prospectively collected fresh-frozen aortic tissue from patients with TAA and donor controls across anatomically distinct regions of the thoracic aorta: root, proximal, mid, and distal ascending. Patients were classified into root- or ascending-dominant phenotypes based on maximally dilatied regions. Bulk ATAC-seq was used to profile chromatin accessibility in TAAs, bulk methylation to assess CpG methylation, and snRNA-seq to compare dilated vs. non-dilated segments in ascending-dominant TAAs. DESeq2 identified differentially accessible peaks and methylated regions (q < 0.05, log2FC > 0), while HOMER assessed transcription factor (TF) motif enrichment. Results: We analyzed 23 segments from 12 individuals (20 segments from 11 TAA patients, 3 segments from 1 donor control). All samples were profiled using ATAC-seq. DNA methylation profiling was performed on 6 samples from 3 patients, and snRNA-seq was conducted on 4 samples from 2 patients. Principal component analysis of 158,420 ATAC-seq peaks clearly separated TAA and control samples, including TAA subtypes. We identified 731 differentially accessible peaks in TAA samples linked to genes implicated in TAA pathogenesis, including KLF4 (log2FC=1.1, q=0.02). Motif analysis revealed enrichment of over 200 TF binding sites that were distinct between TAA phenotypes. Chromatin accessibility and DNA methylation scores were inversely correlated in promoter regions (r = –0.31, p < 2.2e-16), consistent with regulatory activity. From 41,791 nuclei profiled by snRNA-seq, we identified 10 distinct cell clusters, with 4 VSMC clusters comprising the majority (80.9%). TF motifs from differentially accessible peaks had higher expression in VSMCs from dilated samples. Conclusion: Our integrative analysis reveals a distinct coupling between chromatin accessibility and gene expression in TAAs, suggesting a stable and unique cis -regulatory architecture in VSMCs. We identify chromatin accessibility changes and transcriptional programs associated with VSMC dysfunction that warrant further exploration.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (12)

T

Talal El Zarif

Yale University School of Medicine, New Haven, Connecticut, United States

D

Dustin Lieu

Yale University School of Medicine, New Haven, Connecticut, United States

P

Patryk Dabek

Yale University School of Medicine, New Haven, Connecticut, United States

S

Sam Fenske

Yale University School of Medicine, New Haven, Connecticut, United States

A

Ashley Fung

Yale University School of Medicine, New Haven, Connecticut, United States

J

Joshua Yon

Yale University School of Medicine, New Haven, Connecticut, United States

A

Alan Chou

Yale University School of Medicine, New Haven, Connecticut, United States

G

Georgio Maroun

Yale University School of Medicine, New Haven, Connecticut, United States

P

Pengwei Ren

G

George Tellides

R

Roland Assi

Yale University, New Haven, Connecticut, United States

H

Hattie Chung

Yale University School of Medicine, New Haven, Connecticut, United States